Informed consent to undergo serum screening for Down's syndrome: the gap between policy and practice.
作者信息
Smith D K, Shaw R W, Marteau T M
机构信息
Psychology and Genetics Research Group, United Medical School of Guy's Hospital, London.
出版信息
BMJ. 1994 Sep 24;309(6957):776. doi: 10.1136/bmj.309.6957.776.
Abstract
摘要
相似文献
1
Informed consent to undergo serum screening for Down's syndrome: the gap between policy and practice.关于进行唐氏综合征血清筛查的知情同意：政策与实践之间的差距。
BMJ. 1994 Sep 24;309(6957):776. doi: 10.1136/bmj.309.6957.776.
2
Psychological consequences of screening for Down's syndrome.唐氏综合征筛查的心理影响。
BMJ. 1993 Jul 17;307(6897):146-7. doi: 10.1136/bmj.307.6897.146.
3
Serum screening for Down's syndrome: some women's experiences.唐氏综合征血清筛查：部分女性的经历。
BMJ. 1993 Jul 17;307(6897):174-6. doi: 10.1136/bmj.307.6897.174.
4
Biochemical screening for Down's syndrome.唐氏综合征的生化筛查
BMJ. 1993 Jun 26;306(6894):1705-6. doi: 10.1136/bmj.306.6894.1705.
5
Serum screening for Down's syndrome. Informed consent is vital..唐氏综合征血清筛查。知情同意至关重要。
BMJ. 1993 Aug 21;307(6902):500-1. doi: 10.1136/bmj.307.6902.500-c.
6
Do pregnant women in Greece make informed choices about antenatal screening for Down's syndrome? A questionnaire survey.希腊的孕妇是否会对唐氏综合征产前筛查做出明智的选择？一项问卷调查。
Midwifery. 2008 Jun;24(2):153-62. doi: 10.1016/j.midw.2006.09.001. Epub 2007 Feb 20.
7
A Down's diagnosis.唐氏综合征诊断。
Midwives. 2017;20:74-76.
8
Prenatal screening for Down's syndrome--a search for the family's values.唐氏综合征的产前筛查——探寻家庭价值观。
N Engl J Med. 1999 Aug 12;341(7):521-2. doi: 10.1056/NEJM199908123410709.
9
Serum screening for Down's syndrome. National policy would ensure consistency.唐氏综合征血清筛查。国家政策将确保一致性。
BMJ. 1994 Nov 19;309(6965):1372-3.
10
Serum screening for Down's syndrome: experiences of obstetricians in England and Wales.唐氏综合征的血清筛查：英格兰和威尔士产科医生的经验
BMJ. 1994 Sep 24;309(6957):769-72. doi: 10.1136/bmj.309.6957.769.
引用本文的文献
1
Pregnant Hispanic women's views and knowledge of prenatal genetic testing.西班牙语裔孕妇对产前基因检测的看法和了解。
J Genet Couns. 2021 Jun;30(3):838-848. doi: 10.1002/jgc4.1383. Epub 2021 Jan 26.
2
Is routine prenatal screening and testing fundamentally incompatible with a commitment to reproductive choice? Learning from the historical context.常规产前筛查和检测是否从根本上与生殖选择权相悖？从历史背景中学习。
Med Health Care Philos. 2021 Mar;24(1):73-83. doi: 10.1007/s11019-020-09985-w. Epub 2020 Oct 30.
3
Patient-Health Care Provider Conversations About Prenatal Genetic Screening: Recommendation or Personal Choice.患者与医疗保健提供者关于产前基因筛查的对话：建议还是个人选择。
Obstet Gynecol. 2016 Jun;127(6):1145-1152. doi: 10.1097/AOG.0000000000001433.
4
Measuring informed choice in population-based reproductive genetic screening: a systematic review.基于人群的生殖基因筛查中知情选择的衡量：一项系统综述。
Eur J Hum Genet. 2015 Jan;23(1):8-21. doi: 10.1038/ejhg.2014.89. Epub 2014 May 21.
5
"Testing times, challenging choices": an Australian study of prenatal genetic counseling.“艰难时刻，艰难抉择”：一项关于澳大利亚产前遗传咨询的研究
J Genet Couns. 2010 Feb;19(1):22-37. doi: 10.1007/s10897-009-9248-6. Epub 2009 Oct 2.
6
Does labeling prenatal screening test results as negative or positive affect a woman's responses?将产前筛查测试结果标记为阴性或阳性会影响女性的反应吗？
Am J Obstet Gynecol. 2007 Nov;197(5):528.e1-6. doi: 10.1016/j.ajog.2007.03.076. Epub 2007 Sep 19.
7
Antenatal screening policies for Down's syndrome. Audit of Down's syndrome screening is not valid.唐氏综合征的产前筛查政策。唐氏综合征筛查的审计无效。
BMJ. 2002 Nov 2;325(7371):1034; author reply 1034.
8
The potential contribution of decision aids to screening programmes.决策辅助工具对筛查项目的潜在贡献。
Health Expect. 2001 Jun;4(2):109-15. doi: 10.1046/j.1369-6513.2001.00141.x.
9
A measure of informed choice.知情选择的一种衡量方式。
Health Expect. 2001 Jun;4(2):99-108. doi: 10.1046/j.1369-6513.2001.00140.x.
10
Information about screening - is it to achieve high uptake or to ensure informed choice?关于筛查的信息——是为了实现高参与率还是确保知情选择？
Health Expect. 2001 Jun;4(2):92-8. doi: 10.1046/j.1369-6513.2001.00138.x.
本文引用的文献
1
Presenting a routine screening test in antenatal care: practice observed.介绍产前护理中的一项常规筛查试验：观察到的实践情况。
Public Health. 1992 Mar;106(2):131-41. doi: 10.1016/s0033-3506(05)80390-7.
Zotero 插件